/ |

E-cigarettes could save millions of lives, British conference told



Switching to e-cigarettes could save millions of smokers’ lives, a conference on the increasingly popular devices heard Tuesday, though some experts warned more research on the health effects is needed.

The merits of e-cigarettes were thrashed out at a one-day gathering of some 250 scientists, policy-makers, industry figures and enthusiasts at the Royal Society in London.

The use of electronic cigarettes — battery-powered devices that simulate smoking by heating and vaporizing a liquid solution containing nicotine — has grown rapidly, with tobacco manufacturers jumping on the trend. Sales have doubled annually for the last four years and there are an estimated 7 million users across Europe, organizers said.

European lawmakers in October threw out a bid to curb sales of e-cigarettes by classifying them as medicinal products.

Delegates in London debated how the market had moved faster than science or the law. Many delegates merrily “vaped” away throughout the indoor conference sessions, including one man puffing on a sizable e-pipe and another on an e-cigar that lit up blue.

“Cigarettes are killing 5.4 million people per year in the world,” said Robert West, a health psychology professor and the director of tobacco studies at Cancer Research UK. He told delegates that switching to e-cigarettes could save millions of lives, but the debate is about “whether that goal can be realized and how best to do it.”

West said almost a third of attempts to quit smoking now involve e-cigarettes.

Though they are estimated to be between 95 and 99 percent safer than smoking regular cigarettes, some countries have banned them and attendees at the conference debated the thorny issue of whether regulation — possibly under medicinal rules — should be enacted. They also discussed e-cigarettes’ potential as a tool to quit smoking or whether they might become a gateway for those who have never smoked.

Deborah Arnott, chief executive of the pressure group Action on Smoking and Heath (ASH), warned that not enough was known about their effects and pointed out that the tobacco companies are snapping up manufacturers.

“ASH thinks that e-cigarettes have significant potential. They are a lot less harmful than smoking,” she said. However, “there’s a real concern that their safety and effectiveness is not guaranteed without regulation.

“The tobacco companies are moving in. For them it’s potentially a ‘Kodak moment’ because if everyone moved to e-cigarettes, they’d lose their market so they’ve got to be in there. A lot of the bigger e-cigarette companies have already been bought up,” she said.

She warned: “If there are carcinogens in there, you won’t see an immediate effect, but 10, 15, 20 years down the line, people will be dying from that. The development of e-cigarettes is definitely running ahead of the science.”

Jacques Le Houezec, a consultant in public health and tobacco dependence from France, told delegates that while e-cigarettes containe some harmful substances, the levels of toxicants are nine to 450 times lower than in tobacco smoke.

Matthew Moden, a director of English firm Liberty Flights, which makes e-liquid from pharmaceutical-grade nicotine, said that since starting in 2009 as an online retailer with three workers, exponential demand has seen the company’s workforce swell to 75 across 10 stores. They sell a starter kit for £25 ($40), while a refill costs £4.85 for 10 milliliters. An average user might get through 1 to 3 milliliters per day, he said. A typical packet of 20 tobacco cigarettes can cost around £8 in Britain.

“Our customers always refer to this as the product that helped them to stop smoking,” he said, adding the e-liquids come in a multitude of flavours, including menthol and forest fruits. “We welcome regulation. We need to be transparent with what we’re selling, how safe it is and where it comes from.

“In 10, 12, 20 years’ time, I think nicotine will be akin to caffeine in regard to how people consume it, how it’s considered and the effect it has on the body,” said Moden.

Public health commentator Clive Bates said the current light touch regulation had engendered the rapid innovation within the industry, with e-cigarettes now in a “third generation.”

“If you clamp down on all of that with regulation . . . only the tobacco manufacturers will be able to afford the costs,” he said. “It’s a trap.”

Afterward the conference, e-cigarette enthusiasts, or “vapers,” gathered at a nearby pub — standing outside, like regular smokers have to in order to smoke tobacco — puffing away and showing one another their custom-made equipment.